Provided By PR Newswire
Last update: Jan 2, 2025
NEW YORK, Jan. 2, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Neurogene Inc. ("Neurogene" or the "Company") (NASDAQ: NGNE). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.
Read more at prnewswire.comNASDAQ:NGNE (8/21/2025, 8:00:02 PM)
19.75
+0.14 (+0.71%)
Find more stocks in the Stock Screener